# A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults

> **NCT07047521** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Takeda** · enrollment: 496 (actual)

## Conditions studied

- Dengue Fever

## Interventions

- **BIOLOGICAL:** Tetravalent Dengue Vaccine (TDV)

## Key facts

- **NCT ID:** NCT07047521
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-07
- **Primary completion:** 2026-08-30
- **Final completion:** 2027-07-30
- **Target enrollment:** 496 (ACTUAL)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07047521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07047521, "A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07047521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*